Is the ChondroFiller Injection Right for You?
If you are considering the ChondroFiller injection, the most practical question is what the experience actually involves — from the consultation through to resuming everyday activity. Because this is a non-surgical procedure, the pathway looks very different from a keyhole cartilage operation: there is no theatre, no general anaesthetic, and no prolonged protected weight-bearing phase. Understanding those differences helps you plan realistically and get the most from the treatment.
What Is the ChondroFiller Injection?
ChondroFiller is a CE-marked (Class III medical device) acellular Type I collagen hydrogel manufactured by Meidrix Biomedicals in Germany. When delivered as an injection, it is placed directly into a joint under ultrasound guidance through a fine needle, with no incision. Once inside the joint, the two-component system gels within a few minutes, forming a scaffold that recruits the body's own progenitor cells to support cartilage repair. The device is cell-free and does not contain the patient's own stem cells; that distinction belongs to the surgical Liquid Cartilage protocol, which combines the ChondroFiller scaffold with biological adjuncts and, where indicated, mesenchymal stem cells during keyhole surgery.
The injection pathway is suited to accessible cartilage lesions and smaller joints. It acts as a regenerative layer over the affected surface. Evidence from published clinical series suggests meaningful improvements in pain and function scores over twelve to thirty-six months, though individual outcomes vary and the treatment does not reverse established arthritis.
Getting Ready for Your Injection
Your journey begins with a thorough consultation, during which your clinician reviews your history, symptoms, and imaging. Scores such as the IKDC (International Knee Documentation Committee) may be used to establish a baseline and assess whether the injection is the appropriate pathway for your joint and defect size. If the defect is larger or affects a major load-bearing joint such as the knee or hip, your clinician may instead discuss the Liquid Cartilage surgical protocol, which provides a more intensive reconstruction.
In the weeks before the injection, simple health optimisation is worthwhile: maintaining a balanced diet, staying well hydrated, avoiding smoking, and reviewing any medications that could affect healing or clotting. Your clinician will give specific instructions; follow these rather than general guidance.
On the Day of the Injection
No general anaesthetic is required. The ChondroFiller gel is handled carefully to keep it within the narrow temperature range needed for reliable gelation — the two-component syringe system mixes as it is delivered, triggering the collagen to set within a few minutes at body temperature. Your clinician positions the needle accurately using ultrasound guidance so that the scaffold is placed at the defect site. The joint is kept in the correct position briefly while the gel sets. The whole procedure is done as an outpatient and you leave the same day.
In the Days Immediately After
Because no incision is made and no surgical preparation of the joint surface is performed, early recovery from the injection is typically straightforward. Most people do not need crutches or a protective brace. Some localised discomfort or mild swelling in the joint is normal in the first few days as part of the inflammatory healing response; this generally settles without intervention.
In the first one to two weeks, avoid sudden high loads on the joint — heavy gym work, prolonged standing, or high-impact activity — while the scaffold is stabilising. Your clinician or physiotherapist will advise on the appropriate level of activity for your joint and defect. This rest period is considerably shorter than the four-to-six-week protected phase required after the Liquid Cartilage keyhole surgical procedure, where the scaffold needs time to bond in a surgically prepared defect.
Returning to Activity
After the initial rest period, gradual build-up is the guiding principle. Where your clinician recommends physiotherapy, this supports the return of strength, range of motion, and confidence in the joint. Low-impact activities such as swimming and cycling can typically be resumed within two to four weeks, depending on how the joint is responding. Return to higher-impact activity follows when the joint feels settled and your clinician is satisfied with progress.
The biological process continues well beyond the early weeks. Evidence suggests the collagen scaffold is gradually resorbed and replaced by the patient's own tissue over a period of one to two years. Early subjective improvement in pain and function may be apparent sooner, but the full biological repair takes time. This is why follow-up with your clinical team matters: it allows progress to be monitored and any concerns to be addressed promptly.
Expectations and Limitations
The ChondroFiller injection is a joint-preservation treatment, not a cure for arthritis. In published clinical series, patients with localised cartilage defects have reported clinically meaningful reductions in pain and improvements in function. The device has an exceptionally low complication rate across a large number of clinical uses. However, results vary depending on the size and grade of the defect, the joint affected, general health, and adherence to aftercare advice. Patients with advanced or widespread osteoarthritis are less likely to benefit and would usually not be offered this treatment.
Working with Your Clinical Team
Following your clinician's guidance on activity, attending any recommended physiotherapy, and maintaining open communication with the team throughout recovery all contribute to the best possible outcome. If symptoms change unexpectedly — increased swelling, new pain, or loss of movement — contact your team rather than waiting for a routine appointment.
Next Steps
If you are considering the ChondroFiller injection and would like a specialist assessment, London Cartilage Clinic offers consultations at its Harley Street practice. A thorough evaluation will establish whether the injection pathway is appropriate for your joint, or whether a surgical approach such as the Liquid Cartilage keyhole procedure would give a better outcome.
Reference
Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.
Frequently Asked Questions
- ChondroFiller is a CE-marked Class III medical device — an acellular Type I collagen hydrogel scaffold. When injected into a joint under ultrasound guidance, it gels within a few minutes and provides a matrix that recruits the body's own progenitor cells to support cartilage repair. It is a non-surgical outpatient treatment with no incision or general anaesthetic. It does not cure or reverse arthritis, and outcomes vary.
- The difference is significant. After the ChondroFiller injection, most people rest for one to two weeks before gradually resuming activity — there is no surgical preparation of the joint surface and no need for crutches or a prolonged protected phase. After the Liquid Cartilage keyhole surgical procedure, where the defect is prepared and the scaffold is placed arthroscopically alongside biological adjuncts, a protected phase of four to six weeks is typically required before strengthening begins, with a return to higher-impact activity over six to twelve months.
- The two-component ChondroFiller syringe is handled at the correct temperature to ensure reliable gelation. Under ultrasound guidance, the clinician positions a fine needle at the defect site and delivers the scaffold. The joint is held in the correct position briefly while the gel sets. The entire procedure is done as an outpatient appointment.
- Avoid sudden high loading of the joint — heavy exercise, prolonged impact, or sustained weight-bearing — for the first one to two weeks while the scaffold stabilises. Some mild discomfort or swelling is normal initially. Your clinician or physiotherapist will give activity guidance specific to your joint and circumstances.
- Low-impact activities such as swimming and cycling can typically be resumed within two to four weeks, depending on how the joint responds. Return to higher-impact sport follows when the joint has settled and clinical progress supports it. The full biological repair process continues over one to two years, so maintaining contact with your team throughout recovery is advisable.
Where to go from here
A few next steps tailored to what you have just read.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
